CLOV vs VKTX · rev $1.37B vs $3.97B cap
Clover Health Investments Corp (CLOV) versus Viking Therapeutics Inc (VKTX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VKTX revenue for 2025-12-31 was $0. Net income was -$359.6M. VKTX currently screens at market cap $3.97B.
CLOV currently screens at market cap $1.55B. VKTX currently screens at market cap $3.97B.
Not investment advice. Open the CLOV and VKTX stock pages for the full models.
Not investment advice.